2019 PRELIMINARy Conference Program


WEDNESDAY, September 25, 2019  

1:00 pm - 2:00 pm

Welcome

Ton Schumacher, Netherlands Cancer Institute, Amsterdam, The Netherlands

2:00 pm - 4:00 pm

Session 1: Cancer Prevention and Lifestyle Factors in Oncoimmunology

Olivera J. Finn, University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania

Guido Kroemer, Centre de Recherche des Cordeliers, Paris, France

Yuting Ma, Suzhou Institute of Systems Medicine, Suzhou, China

4:00 pm - 4:30 pm

Coffee break

4:30 pm - 6:30 pm

Session 2: Combination Therapies with Immune Checkpoint Blockers

Alexander Eggermont, Gustave Roussy Cancer Center, Villjuif, France

Elizabeth M. Jaffee, Johns Hopkins University School of Medicine, Baltimore, Maryland

Cornelis J.M. Melief, Leiden University Medical Center and ISA Pharmaceuticals BV, Leiden, The Netherlands

starting from 6:30 pm

Cocktail reception


THURSDAY, SEPTEMBER 26, 2019

8:00 am - 9:00 am

William B. Coley Lecture

9:00 am - 11:00 am

Session 3: T Cell Exhaustion – mechanisms: Resistance Mechanisms        

W. Nicholas Haining, Dana-Farber Cancer Institute, Boston, Massachusetts

Dietmar Zehn, Technical University of Munich, Freising, Germany

David Brooks, Princess Margaret Cancer Centre, Toronto, Canada

11:00 am - 1:00 pm

Session 4: Immunotherapies, Non-Cell-Based

Ugur Sahin, BioNTech, Mainz, Germany

Ira Mellman, Genentech, San Francisco, California

1:00 pm - 3:00 pm

Lunch and Poster Session A and Exhibits

3:00 pm - 4:30 pm

Session 5: Immunotherapies, Cell Based

Carl G. Figdor, Radboud University Nijmegen, Nijmegen, The Netherlands

Helen E. Heslop, Baylor College of Medicine, Houston, Texas

Kole Roybal, University of California San Francisco, San Francisco, California

4:30 pm - 5:00 pm

Coffee break

5:00 pm - 6.30 pm

Session 6: New Targets and Concepts

Ellen Puré, University of Pennsylvania, Philadelphia, Pennsylvania

Thea D. Tlsty, University of California San Francisco, San Francisco, California

Susan Kaech, Salk Institute for Biological Studies, La Jolla, California

6:30 pm - 8:00 pm

Drinks and Poster Session A


Friday, SEPTEMBER 27, 2019

9:00 am - 11:00 am

Session 7: Tumor Antigens

Yardena Samuels, Weizmann Institute of Science, Rehovot, Israel

Robert D. Schreiber, Washington University School of Medicine, St Louis, Missouri

John C. Reed, Roche, Basel, Switzerland

11:00 am - 1:00 pm

Session 8: Vaccination Strategies

Sandra Demaria, Weill Cornell Medical College, New York City, New York

Sebastian Kreiter, BioNTech AG, Mainz, Germany

Özlem Türeci, BioNTech AG, Mainz, Germany

1:00 pm - 3:00 pm

Lunch and Poster Session B and Exhibits

3:00 pm - 4:30 pm

Session 9: New Trends in Technology & Informatics

Hannah Carter, University of California San Diego, La Jolla, California

E. John Wherry, Institute for immunology, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania

Michal Bassani-Sternberg, Lausanne University Hospital, Lausanne, Switzerland

4:30 pm - 5:00 pm

Coffee break

5:00 pm - 6:30 pm

Session 10: Microbiota in Oncoimmunology

Laurence Zitvogel, Gustave Roussy Cancer Center, Villejuif, France

Giorgio Trinchieri, National Cancer Institute, Frederick, Maryland

Jennifer A. Wargo, The University of Texas MD Anderson Cancer Center, Houston, Texas

6:30 pm - 8:00 pm

Drinks and Poster Session B


Saturday, September 28, 2019

9:00 am - 11:00 am

Session 11: Onco- and Immunometabolism

Greg M. Delgoffe, University of Pittsburgh, Pittsburgh, Pennsylvania

Ursula Grohmann, University of Perugia, Perugia, Italy

11:00 am - 1:00 pm

Session 12: TME Analysis

Wolf Hervé Fridman, Centre de Recherche des Cordeliers, Paris, France

Nir Hacohen, Massachusetts General Hospital and Broad Institute, Cambridge, Massachusetts

Miriam Merad, Icahn School of Medicine at Mount Sinai, New York, New York

Closing remarks